Does SUNITINIB MALATE Cause Hepatic neoplasm? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hepatic neoplasm have been filed in association with SUNITINIB MALATE (Sunitinib malate). This represents 0.1% of all adverse event reports for SUNITINIB MALATE.
10
Reports of Hepatic neoplasm with SUNITINIB MALATE
0.1%
of all SUNITINIB MALATE reports
3
Deaths
1
Hospitalizations
How Dangerous Is Hepatic neoplasm From SUNITINIB MALATE?
Of the 10 reports, 3 (30.0%) resulted in death, 1 (10.0%) required hospitalization.
Is Hepatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUNITINIB MALATE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does SUNITINIB MALATE Cause?
Death (4,385)
Diarrhoea (3,044)
Fatigue (2,865)
Nausea (2,032)
Neoplasm progression (1,920)
Disease progression (1,745)
Decreased appetite (1,676)
Asthenia (1,651)
Vomiting (1,331)
Dysgeusia (1,226)
What Other Drugs Cause Hepatic neoplasm?
OCTREOTIDE (300)
ADALIMUMAB (98)
LANREOTIDE (85)
EVEROLIMUS (84)
AMLODIPINE (74)
ROSUVASTATIN (55)
IMATINIB (51)
BEVACIZUMAB (49)
RIBAVIRIN (49)
METFORMIN (47)
Which SUNITINIB MALATE Alternatives Have Lower Hepatic neoplasm Risk?
SUNITINIB MALATE vs SUTENT
SUNITINIB MALATE vs SUTIMLIMAB-JOME
SUNITINIB MALATE vs SUVOREXANT
SUNITINIB MALATE vs SUZETRIGINE
SUNITINIB MALATE vs SYMBICORT